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Abstract 
The present study investigated the gastric emptying rate in Göttingen minipigs pre- and post-
prandial and evaluated the effect of metoclopramide on the same parameter, using paracetamol 
as an absorption marker. The pharmacokinetic evaluation of the obtained plasma concentration 
data for paracetamol demonstrated that the fastest gastric emptying rate was observed in the 
animals that were allowed access to normal pig food.  There were no significant difference in 
the stomach emptying rate observed between fasted and fed minipigs, when fed either with a 
FDA standard breakfast or a nutritional energy drink. Pre-dosing minipigs with metoclopramide 
(0.2 or 0.4 mg/kg) did not demonstrate any effect on gastric emptying in either the fasted or fed 
state. The data in the present study demonstrated a relatively prolonged gastric emptying rate 
in mini-pigs both in the fasted and fed state, hence when conducting pharmacokinetic studies 
using mini-pigs, this should be taken into account in planning the plasma sampling time points. 
Further, as no difference could be observe in gastric emptying rate as a function of food the 
data also suggest that the Göttingen minipigs seems less suited to predict for food effect studies 
than other species. 
 
Keywords; gastric emptying, mini-pigs, metoclopramide, fasted state, fed state  
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1 Introduction 
Reliable pre-clinical models for accurate evaluations of different formulations during drug 
development can be important to enable shorter development timelines. Here the pig model has 
shown good promise, given the physiological similarities to humans, where there is a general 
agreement that pigs could be a useful model for human oral absorption (Bode et al., 2010; 
Kararli, 1995; Merchant et al., 2011; Sjogren et al., 2014; Walters et al., 2011) and thereby a 
potential valuable tool in drug formulation development.  
 
Gastric emptying is a fundamental factor influencing drug absorption, given that any change in 
stomach emptying will influence the rate at which drug is presented for absorption in the small 
intestine. The transit time between the stomach and the small intestine is, therefore an important 
characteristic in the oral absorption process. Gastric emptying rates in various races of pigs 
have been reported to show high inter-individual and inter-study variability. Hossain et al. 
(1990) and Oberle and Das (1994) observed a long gastric emptying rate in landrace pigs, in 
the range of 6-24 h. In contrast to this, Davis et al. (2001) reported gastric emptying times after 
a light meal to be closer to 6 h in landrace pigs. While historically, landrace pigs were the most 
widely used species, in recent times, minipigs and in particular the Göttingen minipig have 
become common in pre-clinical studies (Forster et al., 2010). However, relatively few studies 
investigating gastric emptying in minipigs have been reported in the literature. Christiansen et 
al. (2015) investigated the potential of a fed state model developed for dogs in Göttingen 
minipigs, but the reported data demonstrated that the protocol was not able to differentiate 
between a drug with positive or negative food effect.  The study also reported relatively long 
gastric emptying rates in minipigs. Suenderhauf and co-workers (2014) assessed the 
pharmacokinetics of paracetamol in fasted Göttingen minipigs to assess gastric emptying times. 
The study found that gastric transit times in overnight fasted minipigs were longer than those 
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observed in humans. The study also highlighted the need of further work to develop effective 
fasting protocols for minipigs, as it was observed that a 12 hour fasting period was not sufficient 
to obtain an empty stomach in the animals based on the residual stomach contents measured 
post-mortem. Interestingly, minipigs that received 0.2 mg/kg metoclopramide i.m 2 h before 
necropsy had macroscopically empty stomachs, suggesting that this pre-treatment protocol with 
this pro-kinetic agent could be a feasible protocol to ensure consistent fasted state in minipigs.  
 
The amount and type of food ingested can have a significant influence on gastric emptying and 
resultant oral drug bioavailability (Houghton et al., 1990; McLaughlin et al., 1998), and for this 
reason, it is a regulatory requirement to conduct fed and fasted state human clinical studies for 
all new oral medicines.  Given the increasing need to streamline drug product development and 
avoid costly delays in clinical testing, pre-clinical in vivo models are an important tool to assess 
food dependent oral bioavailability– with a view to either predict likely food effects in humans 
or develop food independent formulation strategies. Currently, a pre-clinical food effect model 
is described in dogs (Lentz et al., 2007), but given the similarities between humans and pigs 
gastrointestinal physiology, it is pertinent to consider the development of a protocol for food 
effect studies in the pigs. The Christiansen et al. (2015) study demonstrated that the protocol 
for dogs could not be transferred directly to minipigs due to the long gastric emptying rate 
observed relative to humans. However the observations by Suenderhauf et al. (2014) involving 
pre-treatment with 0.2 mg/kg metoclopramide to ensure gastric emptying represents a 
potentially interesting approach to ensure to developing a protocol in minipigs.  
 
Paracetamol is known to be poorly absorbed in the stomach, but rapidly absorbed upon entry 
into the small intestine, which makes it a good marker when examining gastric emptying rate 
(Clements et al., 1978; Heading et al., 1973). The aim of the present study was to investigate 
the gastric emptying rate in Göttingen minipigs in the pre- and post-prandial state after 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
Page 5 
 
administration of different food sources as well examining the impact of pre-administration of 
metoclopramide on paracetamol absorption under varying prandial conditions.  
 
2 Materials and methods 
2.1 Materials 
500 mg paracetamol (Panodil®) film-coated tablets was obtained from Glaxo Smithkline 
(Brentford, UK). Fresubin energy drink ® was from Fresenius Kabi (Bad Homburg, Germany). 
Paracetamol and metoclopramide was purchased from Sigma-Aldrich Co (St.Louis, MO, USA) 
and sodium chloride from Fluka Chemie AG (Buchs, Switzerland). Purified water was obtained 
from a Millipore Milli-Q Ultrapure Water purification system (Billeria, MA, USA). All other 
chemicals were of analytical grade. 
 
2.2 In vivo study 
The protocol used for the in vivo study was approved by the institutional animal ethics 
committee in accordance with Danish law regulating experiments on animals and in compliance 
with EC directive 2010/63/EU and the NIH guidelines on animal welfare. Female Göttingen 
minipigs were obtained from Ellegaard Göttingen Minipigs A/S (Dalmose, Denmark) weighing 
9.1-11.3 kg at the start and 15.5-18.3 kg at the end of the study. Animals were acclimatised for 
14 days before initiation of the study. During the acclimatisation period, animals were trained 
to eat both FDA standard breakfast (800- 1000 kcal) and the Fresubin energy drink (375 kcal). 
The FDA standard breakfast consisted of two slices of bacon, two slices of buttered toast, two 
fried eggs, eight ounces of full milk, and four ounces of hash browns, which was homogenised 
and presented to the animals. Altromin 9023 (602 kcal; contains 25 fat kg-1, 135 g protein kg-
1). was utilized as a normal pig food, the pigs were fed 120 g twice a day. The minipigs were 
examined weekly by a veterinarian and observed closely at the end of each experimental day. 
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Before entering the experiment, minipigs were fasted for 18–20 h with free access to water. 
They were housed with straw as bedding and stabled individually from the fasting period until 
the last blood sample was taken. Minipigs were kept on a 12 h light and 12 h night cycle 
throughout the experiment. 
 
The study design was a non-randomized one sequence design with a 7-day wash-out period 
between treatments. Minipigs (n = 6) were weighed on the day and orally dosed with 2 tablets 
of paracetamol (1000 mg). A total sample size of 6 animals was required to achieve significance 
for comparisons between groups, using a paired t-test to assess difference between at a 
significance level of p = 0.05. These calculations were performed on G Power (version 3.1.9.2 
University Kiel, Germany) and were based on an effect size 1.5, α error probability 0.05, and 
with a power of 0.80. 
 
The following treatment groups were conducted: 
1. Fasted (Fasted) 
2. FDA breakfast 30 min before dosing (FEDFDA breakfast) 
3. 250 ml Fresubin energy drink 30 min before administration (FEDEnergy drink) 
4. Free access to normal pig food, fed in the mornings (FEDpig food) 
5. Fasted and 0,2 mg/kg metoclopramide intramuscular 2 h before dosing 
(FASTEDMCP 0.2 mg/kg) 
6. Fasted and 0,4 mg/kg metoclopramide intramuscular 2 h before dosing 
(FASTEDMCP 0.4 mg/kg) 
7. Pre-treatment with 0.4 mg/kg metoclopramide intramuscular 2 h and FDA breakfast 
30 min before dosing (FEDFDA breakfast
MCP 0.4mg/kg
) 
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8. Pre-treatment with 0.4 mg/kg metoclopramide intramuscular 2 h and 250 mL Fresubin 
energy drink 30 min before dosing (FEDEnergy drink
MCP 0.4mg/kg
) 
 
In addition, the animals were administered paracetamol intravenously. The intravenous 
paracetamol formulation contained 24 mg paracetamol/mL, which was dissolved in purified 
water containing 0.7% (w/v) NaCl, and the pH was adjusted to 8.0.  Each animal received 10 
mL, i.e. a dose of 240 mg. 
 
4 mg/mL metoclopramide solution for intramuscular injection was prepared in 0.9% sterile 
NaCl by magnetic stirring at ambient temperature and subsequent aseptic filtering through a 
sterile 0.22 μm filter into a sterile vial. The intramuscular dose was therefore 0.5 or 1 mL/10 
kg, for the 2 and 4 mg/kg dose, respectively. Metoclopramide was injected intramuscularly two 
hours before paracetamol dosing and the food or energy drink was presented to the animals 30 
min prior to oral dosing of the paracetamol tablets. In all cases the animals finished their meals 
quickly.  
 
Blood samples (3.0 mL) were obtained by individual vein puncture of the vena jugularis. Blood 
samples were collected at 5, 15, 30 min 1, 2, 4, and 7 h after drug administration. Blood samples 
were collected into ethylenediaminetetraacetic acid (EDTA) coated tubes and immediately 
centrifuged for 10 min at 4 ºC, 2765g (Centrifuge Multifuge 1 S-R; Heraeus, Hanau, Germany). 
Plasma was harvested and stored at −80ºC until analysis. 
 
2.3 Bioanalysis 
Plasma concentrations of paracetamol were measured by liquid chromatography coupled to 
tandem mass spectrometry (LC-MS/MS) as previously described (Christiansen et al., 2015). In 
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short, calibration standards and quality control (QC) samples were prepared by spiking drug-
free porcine plasma and an internal standard [deuterated paracetamol (Toronto Research 
Chemicals Inc., Toronto, Ontario, Canada), in 10% trichloroacetic acid] was added to 10 µL of 
the calibration standards. The inter-assay inaccuracy was within ±15 % for all concentrations. 
 
The MS peak area correlated linearly with the plasma concentration of the paracetamol in the 
range of 10–2000 ng/mL. If plasma concentrations exceeded the linear range, appropriate 
dilution was performed. 
 
2.4 Pharmacokinetic Analysis 
The pharmacokinetics of paracetamol in plasma of individual pigs was determined. After 
intravenous administration, the pharmacokinetic parameters for paracetamol were determined 
using compartmental pharmacokinetic analysis. Following oral administration of paracetamol, 
the area under the plasma concentration time curve (AUC), and mean residence time (MRT) 
were determined from non-compartmental analysis. Absolute bioavailability (Fabs) is defined 
as follows: 
𝐹𝑎𝑏𝑠 =  
𝐶𝑙𝑡𝑜𝑡∗ 𝐴𝑈𝐶
𝐷𝑜𝑠𝑒
  (1) 
F was determined as the dose normalised peak areas ratio of the oral to intravenous plasma 
profiles as follows: 
𝐹 𝑎𝑏𝑠
0−7ℎ = (
𝐴𝑈𝐶 𝑜𝑟𝑎𝑙
0−7ℎ
𝐴𝑈𝐶 𝑖.𝑣.
0−7ℎ 
) ∗ (
𝐷𝑜𝑠𝑒𝑖.𝑣.
𝐷𝑜𝑠𝑒𝑜𝑟𝑎𝑙
)(2) 
The area under the curve during the 7 hours sampling period (0-7h) was not consistently >80% 
AUC total (calculated as AUC0-7h plus the AUC of the extrapolated tail segment from 7h- ∞) 
across all treatment groups. As a result, absolute bioavailability was expressed as F abs
0−7h
 
determined using the AUC ratios within the sampling period. 
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Parameters representative of the gastric emptying, equal to the absorption profile included; a) 
the maximum plasma concentration (Cmax), b) the time corresponding to maximum plasma 
concentration (tmax), c) the mean absorption time (MAT), and d) the cumulated absorbed 
amount of paracetamol calculated by deconvolution. 
 
MRT for a drug administered by a non-instantaneous input involves a mean absorption time 
(MAT), and can be defined as follows: 
𝑀𝑅𝑇𝑝𝑜 = 𝑀𝐴𝑇 + 𝑀𝑅𝑇𝑖𝑣   (3) 
where MRTpo and MRTiv represent the mean residence time of oral paracetamol and 
intravenous paracetamol. The MRTiv was based on the intravenous group and MRTpo was 
determined from the six individual animals in each group, hence each individual animal served 
as its own control.  
 
2.5 Deconvolution 
Correlation between time functions, such as absorption and plasma concentrations, can 
mathematically be treated by system analysis (Langenbucher, 1982). The plasma concentration 
profile obtained after oral administration can be treated as the response function R(t), i.e. the 
response observed when administering a compound. W(t) is the weighting function of the body 
system, as observed after intravenous or oral bolus administration. The correlation between the 
weighting and response function depends upon the input and can algebraically be described by 
the integral (Langenbucher, 1982): 
𝑅(𝑡) = ∫ 𝐼(𝜗)𝑊(𝑡 − 𝜃)𝑑𝜃
𝑡
0
   (4) 
where R, I and W are the response, input and weighting functions, respectively. I(t) combines 
the release and absorption process and can be described as release time function. The integral 
of this form is known as the convolution integral, written as: 
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𝑅(𝑡) = 𝐼(𝑡) ∗ 𝑊(𝑡)    (5) 
where * is the convolution operator. In the current study, R(t) and W(t) were known, i.e. I(t) 
representing the absorption process was sought, denoted deconvolution. Langenbucher (1982) 
previously described, the response function R(t), deconvolved with the weight function W(t) 
as:  
𝐼(𝑡) =
𝑅(𝑡)
𝑊 (𝑡)
     (6) 
A number of approaches exists to solve the deconvolution problem (Madden et al., 1996), but 
in the present study numerical deconvolution, as described by Langenbucher (1982), was used 
and approximated with the sum: 
𝐼(𝑥𝑖) =
[𝑅(𝑡) /𝑇−∑ 𝐼(𝑥𝑘)∗𝑊(𝑥𝑛−𝑘+1)
𝑛
𝑘=1 ]
𝑊(𝑥𝑖)
  (7) 
where T is the time interval, I(Xk) and W(Xk) the average input rate and weight between the 
times Xk-1 and Xk. The numerical deconvolution was based on the obtained plasma 
concentration data. The deconvolution profiles provide a dynamic picture of the absorption 
process, and were used to determine the time taken to absorb various fractions of paracetamol. 
The data were normalised across the different treatments and presented as percentage of total 
absorbed paracetamol fraction. Mean time points for 25%, 50% and 75% absorbed paracetamol 
were calculated from the deconvolution profiles.  
 
2.6 Statistical Analysis 
The pharmacokinetic analysis was conducted using the PKPlus™ module in Gastroplus™ (ver. 
9.0, Simulations Plus Inc., Lancaster, Ca.), and the deconvolution was conducted in Excel. 
Results are presented as means and their standard error mean (± S.E.M.). A nonparametric 
statistical test was used, the Kruskal Wallis rank test, with Dunn’s multiple comparison rank 
sums to determine the significance of difference in tmax, AUC, bioavailability and Cmax. All 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
Page 11 
 
statistical analyses were performed using GraphPad Prism version 5, and 5% was considered 
significant. 
 
3 Results and discussion 
In the present study, the gastric emptying rate in Göttingen minipigs was investigated under a 
number of different prandial conditions, including investigation of the influence of pre-dosing 
of metoclopramide.  
 
3.1 Intravenous administration 
In order to assess the disposition kinetics of paracetamol in mini-pigs, a paracetamol solution 
containing 240mg of paracetamol was administered intravenously (i.v.). The paracetamol 
plasma concentration time profile obtained after i.v. administration is shown in Fig. 1. A two-
compartmental model was found to adequately fit the data. The observed volume of distribution 
was 0.83 ± 0.12 L/kg, which was comparable to values reported for mini-pigs elsewhere (0.7 
L/kg) (Suenderhauf et al., 2014). In landrace pigs, a volume of distribution of 1.5 L/kg has been 
reported (Neirinckx et al., 2010). The total clearance of paracetamol in this study was 
determined to be 0.5 ± 0.0 L/(h *kg), which was 50% lower compared to mean systemic 
clearance of paracetamol in landrace pigs of 0.9 L/(h *kg) (Neirinckx et al., 2010). 
 
3.2 Absorption of paracetamol pre- and post-prandial  
Mean plasma concentration time profiles of paracetamol following the eight different dosing 
conditions are shown in Fig. 2 and 3 and the associated mean pharmacokinetic parameters are 
presented in Table 1. Mean absorption time (MAT) is summarized in Fig. 4, and deconvolution 
fractiles in Table 2. In general, a lag phase was observed between oral administration of 
paracetamol and the onset of absorption. 
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3.2.1 Effect of food intake 
Food intake leads to a slower gastric emptying rate, which generally leads to a longer tmax and 
lower Cmax when drug is dosed post- rather than pre- prandially. This may also potentially affect 
the overall extent of drug absorbed (Christiansen et al., 2015). Differences in tmax or other 
pharmacokinetic parameters for paracetamol when dosed either in fasted or fed state would 
therefore reflect how the ingested meal delays gastric emptying, given paracetamol is rapidly 
absorbed once it enters the small intestine. The current study explored the use of tmax, MAT, 
and deconvolution profiles to detect differences in the absorption profiles between the different 
treatment groups investigated, namely: (i) homogenised FDA breakfast, (ii) a nutritional energy 
drink, and (iii) normal pig food 120 g provided twice a day. 
 
Fig. 2A displays the plasma concentration profiles for the four groups: Fasted, FEDPig food, 
FEDFDA breakfast, FEDEnergy drink. While there was a general trend towards a higher AUC in 
the fasted than in the fed state, there were no statistical differences in either AUC or Cmax for 
each treatment group. The time to reach peak concentrations (tmax) of Fasted,  FEDFDA breakfast 
and FEDEnergy drink groups was approximately four hours (see Fig 2B), whereas for the group 
fed with pig food, tmax was reached at 1.6 hours.  
 
The mean plasma concentration profile from the fasted minipigs, showed a second plasma peak, 
which was on closer evaluation of the individual plasma profiles, was present in three of the six 
pigs in the group. For the animals pre-administered with metoclopramide this was only 
observed in one of the six animals. Appearance of double peaks after oral administration is not 
an uncommon phenomenon and have been described previously in the literature for other 
compounds (Charman et al., 1993; Lipka et al., 1995; Metsugi et al., 2008; Takamatsu et al., 
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2002; Languth et al., 1994), and has also been reported for paracetamol (Clements et al., 1978). 
The exact reason for the double peak is unclear, but variable gastric emptying has been 
previously suggested as a cause for the double peaks with paracetamol (Metsugi et al., 2008). 
The occurrence of a second plasma peak in paracetamol plasma profiles in the present study 
may therefore be related to  variable gastric emptying in pigs. 
 
Additionally, one animal in the fasted group had a plasma concentration profile where the 
absorption was incomplete within the 7 hours sampling period, and therefore a distinct 
elimination phase could not be determined from the terminal phase of the plasma profile. This 
may reflect that a truly fasted state was not achieved with a fasting period of 20 hours, as 
suggested by Suenderhauf and co-workers (2014). Comparing the fasted group with the group 
dosed with the nutritional energy drink (Fig 2A), it was apparent that the plasma concentration 
profiles had similar shapes, but the fed state profile was shifted to the right with a lag time of 
one hour. After one hour, the absorption curve closely followed the fasted state curve.  
  
MAT has previously been used to estimate the absorption time (Ikegami et al., 2003; Mizuta et 
al., 1990) with a short MAT indicating fast absorption. The lowest MAT was observed for the 
minipigs fed with pig food (see Fig 2C). The animals receiving the FDA breakfast had a MAT 
similar to fasted minipigs, whereas the group administered with the Fresubin energy drink had 
a slightly longer MAT than the fasted group.  The differences in MAT were not statistically 
significant between the groups.  
 
A similar rank order between groups was observed in the deconvolution profile of paracetamol, 
with the slowest absorption observed for the animals receiving energy drink, followed by fasted,   
FEDFDA breakfast and FEDpig food (see Fig 2D). For the groups receiving pig food or the FDA 
breakfast, there was no significant difference between the deconvolution profiles, and these 
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groups had slightly faster absorption profiles than the animals receiving Energy drink. The 
deconvolution analysis demonstrated that the profile of the animals receiving the Fresubin 
energy drink showed an initial delay of approximately one hour, indicating a delayed absorption 
rate. The use of the energy drink as an energy source therefore led to a different absorption 
profile, relative to both the fasted and the fed stage induced with the FDA standard breakfast. 
 
To compare the differences between the deconvolution profiles in more detail the exact time 
points for 25%, 50% and 75% absorbed paracetamol where calculated, see Table 2. For 
minipigs fed with pig food, 50% of the drug was absorbed after 1.9 hours, whereas for the fasted 
minipigs it took more than 3 hours to absorb 50% of the paracetamol dose. Similar to previous 
findings, this is again indicative of a faster gastric emptying rate in minipigs fed the normal pig 
feed.  Possible reasons for this are unclear but may be related to animal habituation.  Despite 
training of the animals with the different food sources, they still received normal pig food the 
majority of the time, hence, the animals may perceive the normal feed as less stressful or their 
digestive system may simply be better adjusted to normal pig food. This may be reflected in 
the faster gastric emptying rate in these animals. 
 
In summary, the data presented here showed that the fasted group had a trend towards a higher 
extent of absorption when compared to the fed states, but all in all there was no clear and 
significant differences in paracetamol absorption between fasted and fed Göttingen minipigs. 
These findings are in accordance with previous studies (Christiansen et al., 2015). A delayed 
gastric emptying in the fed state groups could be expected, as food has the characteristics to 
delay gastric emptying (Sjogren et al., 2014). Lack of clear difference between the groups 
indicates that a ‘true’ fasted state could not be achieved within a fasting period of 18–20 hours, 
as also previously described in the literature (Suenderhauf et al., 2014). The observed lag times 
for fed state treatment were comparable and similar to human lag times; 0.6-1.4 hours in various 
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fed states (Hellmig et al., 2006). Based on present knowledge the variable absorption rates and 
difficulties in obtaining a true fasted state in minipigs, suggest that the minipig may be less 
useful for food effect studies on pharmaceutical drug formulation development. 
 
3.3 Effect of Metoclopramide on gastric emptying 
Drug absorption in the pre- and post-prandial states are important parameters for new drug 
candidates and their associated formulations during the development process. Christiansen and 
co-workers (2015) reported relative slow gastric emptying in minipigs, which Suenderhauf et 
al. suggested may be overcome by pre-treatment with 0.2 mg/kg of metoclopramide. 
Metoclopramide is a prokinetic agent and accelerates gastric emptying in man (Behar and 
Ramsby, 1978). A similar dose of 0.2 mg/kg metoclopramide was previously used in pigs to 
control gastric emptying (Gregory et al., 1995).  The current study utilised doses of 0.2mg/kg 
and 0.4mg/mg administered 2 hours pre-dosing.  
 
3.3.1 Influence of Metoclopramide in the fasted state 
Administration of 0.2 mg/kg metoclopramide led to a marginally higher tmax and MAT (see 
Table 1), when compared to the fasted group, however the difference were not statistically 
significant and hence gastric emptying was not considered to be influenced by the pre-treatment. 
There was no clear differences in the plasma profiles with dosing at 0.4mg.kg metoclopramide.  
While a trend towards a lower AUC for the group dosed with the 0.4 mg/kg was evident, as 
shown in Table 1, the difference in AUC was not statistically significant.  For both plasma 
profiles, the paracetamol absorption was not fully completed at the end of the plasma sampling 
and no clear elimination phase was identified (Table 1 and Fig. 3A).). 
 
The deconvolution profiles and plasma concentration profiles of the fasted minipigs in 
comparison to the fasted pre-treated minipigs are presented in Fig 3. Overall there was no 
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significant difference in the absorption of paracetamol between the groups (Fig. 3B, D, and F). 
Therefore, the effect of pre-treatment of metoclopramide on lowering food content in the 
stomach of the minipigs observed by Suenderhauf et al. (2014), did not translate into a faster 
gastric transit in our studies, as measured by paracetamol absorption. The reason for the lack of 
effect of metoclopramide on paracetamol absorption in fasted pigs are unclear but may be 
related to the longer fasting period of 18-20 hour applied in our study, compared to 12 hours in 
the Suendefhauf study, with the longer period of fasting allowing for sufficient time for 
complete gastric emptying. 
 
3.3.2 Influence of metoclopramide in the fed state – FDA breakfast 
To assess the influence of metoclopramide on fed state gastric motility, minipigs were pre-
treated with 0.4 mg/kg of metoclopramide 1.5 hours before oral administration of a FDA 
standard breakfast and or a total of 2 hours before oral dosing of paracetamol. The pre-treatment 
of metoclopramide showed no significant effect on tmax or MAT relative to the animals just 
receiving the FDA standard breakfast (see Table 1). A direct comparison of the plasma 
concentration profiles for the two groups are presented in Fig. 3C and the deconvolution profiles 
in Fig. 3D. The group pre-treated with metoclopramide showed a slower absorption and a lag 
time of two hours, however, no significant differences was observed. These data therefore 
suggest that the pre-treatment with metoclopramide did not increase the gastric emptying rate 
in the animals when administered a FDA standard breakfast. The pre-treatment protocol 
investigated had no significant influence on the absorption profile of paracetamol in the fed 
state, and therefore does not provide an approach whereby food effects could be investigated in 
in fed-state minipigs. 
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
Page 17 
 
3.3.3 Influence of metoclopramide in the fed state – nutritional energy drink 
For the animals fed the Fresubin energy drink no significant effect of pre-treatment of 
metoclopramide was observed on tmax and MAT, relative to the fasted group. (Table 1), i.e. the 
gastric emptying rates were equal. Similarly there were no mean plasma concentration time 
profiles comparing FastedMCP 0.2 mg/kgand FedEnergy drink
MCP 0.4 mg/kg
 (Fig. 3A and E). 
 
Fig. 3F summarizes the mean deconvolution profile of the animals receiving 250 mL Fresubin 
energy drink 30 min before the oral administration of paracetamol and minipigs with or without 
pre-treatment of metoclopramide two hours before paracetamol administration. The shape of 
the mean deconvolution profiles from the two groups were similar, but a trend towards an 
increased and faster absorption was observed for the metoclopramide pre-treated minipigs. The 
combination of metoclopramide pre-dosing and nutritional energy drink led to a deconvolution 
profile similar to the one obtained in the fasted animals, as shown in Fig. 3A and E. To reach a 
true fasted state in minipigs, the effect from the pre-treatment with metoclopramide was 
therefore insignificant both for the FDA breakfast and the energy drink. The use of 
metoclopramide, therefore, did not appear to influence the gastric emptying rate in either the 
fasted or any of the two investigated fed states. These data are not fully supportive of the 
observations presented by Suenderhauf and co-workers (2014), which could reflect the 
differences in the methodology between the two studies, namely a fasting period of 18-20 hours 
vs. 12 hours and estimating gastric emptying based on paracetamol absorption versus weighed 
post-mortem stomach contents. 
 
Assuming that paracetamol is a relevant marker for gastric emptying in minipigs, the data in 
the present study confirmed that mini-pigs have a longer gastric emptying rate than man and 
that it was not affected by pre-treatment with 0.2 - 0.4mg/kg metoclopramide. Food did not 
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significantly influence the gastric emptying rate, neither the standard FDA breakfast nor an 
energy drink, and the most reliable protocol was obtained by allowing the mini-pigs to follow 
their normal feeding regime i.e. standard pig food. One limitation of this study is that study is 
based on assessing food effect difference using paracetamol as a marker for gastric emptying, 
whereas it is possible that a drug with a more pronounced food effect in humans may be a more 
reliable marker. An additional limitation of the current study was that the most frequent blood 
sampling was conducted in the first hour after administration, which did not coincide the peak 
plasma concentrations observed for paracetamol (Cpeak) in minipigs. For more reliable 
estimates of t max, frequent blood sampling near the Cpeak are required. Therefore, future 
studies should take the delayed and variable absorption of paracetamol in minipigs into account, 
with more frequent sampling around an estimated window of tmax of 2-6 hours. 
Notwithstanding these limitations, it would appear that based on the current study, the impact 
of food on drug absorption in mini-pigs is highly variable and the investigated protocols are not 
supportive of fed versus fasted studies on oral dosage forms in this species. 
 
4 Conclusion 
The present study investigated gastric emptying rates in fasted and fed Göttingen minipigs and 
evaluated the effect of metoclopramide on the same parameter. The results indicated that a pre-
treatment of metoclopramide did not regulate gastric emptying under any of the investigated 
conditions. In addition, the data demonstrated no significant difference in the stomach emptying 
rate between fasted and fed minipigs. None of the investigate protocols seemed able to induce 
a gastric emptying that would be extended when food was administered, as observed in humans.  
The mini-pig model appears to be less suited for exploring food effect interactions studies than 
other species.  
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
Page 19 
 
5 Acknowledgements 
L.J. Henze, B. Griffin and R. Holm are part of the PEARRL European Training network, which 
has received funding from the Horizon 2020 Marie Sklodowska-Curie Innovative Training 
Networks programme under grant agreement No. 674909.  
 
The experimental part of this study was conducted while R. Holm was employed at H. 
Lundbeck A/S, where the personnel in the animal facilities are highly acknowledged for their 
skilful handling of the minipig study. 
 
References 
Behar, J., Ramsby, G., 1978. Gastric emptying and antral motility in reflux esophagitis. Effect 
of oral metoclopramide. Gastroenterology 74, 253-256. 
Bode, G., Clausing, P., Gervais, F., Loegsted, J., Luft, J., Nogues, V., Sims, J., Project, R., 2010. 
The utility of the minipig as an animal model in regulatory toxicology. J. Pharmacol. 
Toxicol. Meth. 62, 196-220. 
Charman, W.N., Rogge, M.C., Boddy, A.W., Barr, W.H., Berger, B.M., 1993. Absorption of 
danazol after administration to different sites of the gastrointestinal-tract and the 
relationship to single-peak and double-peak phenomena in the plasma profiles. J. Clin. 
Pharmacol. 33, 1207-1213. 
Christiansen, M.L., Müllertz, A., Garmer, M., Kristensen, J., Jacobsen, J., Abrahamsson, B., 
Holm, R., 2015. Evaluation of the use of Göttingen minipigs to predict food effects on 
the oral absorption of drugs in humans. J. Pharm. Sci. 104, 135-143. 
Clements, J.A., Heading, R.C., Nimmo, W.S., Prescott, L.F., 1978. Kinetics of acetaminophen 
absorption and gastric emptying in man. Clin. Pharmacol. Ther. 24, 420-431. 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
Page 20 
 
Davis, S.S., Illum, L., Hinchcliffe, M., 2001. Gastrointestinal transit of dosage forms in the pig. 
J. Pharm. Pharmacol. 53, 33-39. 
Forster, R., Bode, G., Ellegaard, L., van der Laan, J.W., Project, R., 2010. The RETHINK 
project: minipigs as models for the toxicity testing of new medicines and chemicals: an 
impact assessment. J. Pharmacol. Toxicol. Meth. 62, 158-159. 
Gregory, P.C., McFadyen, M., Rayner, D.V., 1995. Control of gastric emptying in the pig: 
influence of cholecystokinin, somatostatin and prokinetic agents. Exp. Physiol. 80, 159-
165. 
Heading, R.C., Nimmo, J., Prescott, L.F., Tothill, P., 1973. The dependence of paracetamol 
absorption on the rate of gastric emptying. Br. J. Pharmacol. 47, 415-421. 
Hellmig, S., Von Schoning, F., Gadow, C., Katsoulis, S., Hedderich, J., Folsch, U.R., Stuber, 
E., 2006. Gastric emptying time of fluids and solids in healthy subjects determined by 
13C breath tests: influence of age, sex and body mass index. J. Gastroenterol. Hepatol. 
21, 1832-1838. 
Hossain, M., Abramowitz, W., Watrous, B.J., Szpunar, G.J., Ayres, J.W., 1990. Gastrointestinal 
transit of nondisintegrating, nonerodible oral dosage forms in pigs. Pharm. Res. 7, 1163-
1166. 
Houghton, L.A., Mangnall, Y.F., Read, N.W., 1990. Effect of incorporating fat into a liquid 
test meal on the relation between intragastric distribution and gastric-emptying in human 
volunteers. Gut 31, 1226-1229. 
Ikegami, K., Tagawa, K., Narisawa, S., Osawa, T., 2003. Suitability of the cynomolgus monkey 
as an animal model for drug absorption studies of oral dosage forms from the viewpoint 
of gastrointestinal physiology. Biol. Pharm. Bull. 26, 1442-1447. 
Kararli, T.T., 1995. Comparison of the gastrointestinal anatomy, physiology, and biochemistry 
of humans and commonly used laboratory animals. Biopharm. Drug Disp. 16, 351-380. 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
Page 21 
 
Langenbucher, F., 1982. Numerical convolution deconvolution as a tool for correlating in vitro 
with in vivo drug availability. Ind. 44, 1166-1172. 
Langguth, P., Lee, K.M., Spahn-Langguth, H., Amidon, G.L., 1994. Variable gastric emptying 
and discontinuities in drug absorption profiles: dependence of rates and extent of 
cimetidine absorption on motility phase and pH. Biopharm. Drug Dispos. 15, 719-746. 
Lentz, K.A., Quitko, M., Morgan, D.G., Grace, J.E., Jr., Gleason, C., Marathe, P.H., 2007. 
Development and validation of a preclinical food effect model. J. Pharm. Sci. 96, 459-
472. 
Lipka, E., Lee, I.D., Langguth, P., Spahn-Langguth, H., Mutschler, E., Amidon, G.L., 1995. 
Celiprolol double-peak occurrence and gastric motility: nonlinear mixed effects modeling 
of bioavailability data obtained in dogs. J. Pharmacokinet. Biopharm. 23, 267-286. 
Madden, F.N., Godfrey, K.R., Chappell, M.J., Hovorka, R., Bates, R.A., 1996. A comparison 
of six deconvolution techniques. J. Pharmacokinet. Biopharm. 24, 283-299. 
McLaughlin, J.T., Troncon, L.E.A., Barlow, J., Heggie, L.J., Thompson, D.G., 1998. Evidence 
for a lipid specific effect in nutrient induced human proximal gastric relaxation. Gut 43, 
248-251. 
Merchant, H.A., McConnell, E.L., Liu, F., Ramaswamy, C., Kulkarni, R.P., Basit, A.W., 
Murdan, S., 2011. Assessment of gastrointestinal pH, fluid and lymphoid tissue in the 
guinea pig, rabbit and pig, and implications for their use in drug development. European 
J. Pharm. Sci. 42, 3-10. 
Metsugi, Y., Miyaji, Y., Ogawara, K., Higaki, K., Kimura, T., 2008. Appearance of double 
peaks in plasma concentration-time profile after oral administration depends on gastric 
emptying profile and weight function. Pharm. Res. 25, 886-895. 
Mizuta, H., Kawazoe, Y., Haga, K., Ogawa, K., 1990. Effects of meals on gastric emptying and 
small intestinal transit times of a suspension in the beagle dog assessed using 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
Page 22 
 
acetaminophen and salicylazosulfapyridine as markers. Chem. Pharm. Bull. 38, 2224-
2227. 
Neirinckx, E., Vervaet, C., De Boever, S., Remon, J.P., Gommeren, K., Daminet, S., De Backer, 
P., Croubels, S., 2010. Species comparison of oral bioavailability, first-pass metabolism 
and pharmacokinetics of acetaminophen. Res. Vet. Sci. 89, 113-119. 
Oberle, R.L., Chen, T.S., Lloyd, C., Barnett, J.L., Owyang, C., Meyer, J., Amidon, G.L., 1990. 
The influence of the interdigestive migrating myoelectric complex on the gastric 
emptying of liquids. Gastroenterology 99, 1275-1282. 
Oberle, R.L., Das, H., 1994. Variability in gastric pH and delayed gastric emptying in Yucatan 
miniature pigs. Pharm. Res. 11, 592-594. 
Sjögren, E., Abrahamsson, B., Augustijns, P., Becker, D., Bolger, M.B., Brewster, M., 
Brouwers, J., Flanagan, T., Harwood, M., Heinen, C., Holm, R., Juretschke, H.P., 
Kubbinga, M., Lindahl, A., Lukacova, V., Munster, U., Neuhoff, S., Nguyen, M.A., van 
Peer, A., Reppas, C., Hodjegan, A.R., Tannergren, C., Weitschies, W., Wilson, C., Zane, 
P., Lennernas, H., Langguth, P., 2014. In vivo methods for drug absorption - Comparative 
physiologies, model selection, correlations with in vitro methods (IVIVC), and 
applications for formulation/API/excipient characterization including food effects. Eur. J. 
Pharm. Sci. 57, 99-151. 
Suenderhauf, C., Tuffin, G., Lorentsen, H., Grimm, H.P., Flament, C., Parrott, N., 2014. 
Pharmacokinetics of paracetamol in Göttingen minipigs: in vivo studies and modeling to 
elucidate physiological determinants of absorption. Pharm. Res. 31, 2696-2707. 
Takamatsu, N., Welage, L.S., Hayashi, Y., Yamamoto, R., Barnett, J.L., Shah, V.P., Lesko, L.J., 
Ramachandran, C., Amidon, G.L., 2002. Variability in cimetidine absorption and plasma 
double peaks following oral administration in the fasted state in humans: correlation with 
antral gastric motility. Eur. J. Pharm. Biopharm. 54, 255-255. 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
Page 23 
 
Walters, E.M., Agca, Y., Ganjam, V., Evans, T., 2011. Animal models got you puzzled?: think 
pig. Ann. N. Y. Acad. Sci. 1245, 63-64. 
ACCEPTED MANUSCRIPT
AC
CE
PTE
D M
AN
US
CR
IPT
Page 24 
 
Table 1. Pharmacokinetic parameters of paracetamol, oral administration 1000 mg per animal (n = 4 - 6) 
Pharmacokinetic parameters 
 Fasted 
 
FastedMCP 0.2 mg/kg 
 
FastedMCP 0.4 mg/kg 
 
FEDPig food 
 
FEDFDA breakfast FEDFDA breakfast
MCP 0.4 mg/kg
 
 
FEDEnergy drink 
 
FEDEnergy drink
MCP 0.4 mg/kg
 
 
Cmax (ng/mL) 27229± 
17009 
25911± 
10808 
17214± 
17656 
20821 ± 
19355 
14504± 
9519 
25488± 
8824 
15109± 
7619 
14641± 
10252 
tmax (h) 4.2 ± 1.6 5.8 ± 1.8 3.9 ± 3.4 1.6 ± 0.9 3.5 ± 2.7 5.6 ± 1.9 4.5 ± 1.2 2.8 ± 1.3 
AUC0→7 
(ngh/mL) 
101018 ± 
51947 
87240 ± 32829 44875 ± 41532 61265 ± 
56062 
42605 ± 33016 86275 ± 19041 54766 ± 27357 56306 ± 43684 
F (%) 86.4 ± 61.1 72.5 ± 42.3 39.2 ± 38.8 51.1 ± 
52.0 
34.8 ± 28.2 71.0 ± 34.4 44.7 ± 28.8 46.6 ± 28.8 
MAT (h) 2.15 ± 0.65 2.66 ± 1.26 2.00 ± 1.15 1.82 ± 
0.86 
1.59 ± 1.60 3.17 ± 0.50 2.62 ± 0.40 1.85 ± 0.57 
MRT p.o. (h) 3.64 ± 0.68 4.10 ± 1.43 3.56 ± 1.32 3.36 ± 
0.90 
3.13 ± 1.67 4.60± 0.66 4.16 ± 0.54 3.40 ± 0.72 
*MCP= Metoclopramide 
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Table 2. Mean deconvolution time points (h) after oral administration of paracetamol 1000 mg (mean, n = 5 - 6) 
Deconvolution summary 
Absorbed fraction 
(%) 
Fasted 
(h) 
FastedMCP 0.2 mg/kg 
(h) 
FastedMCP 0.4 mg/kg 
(h) 
FEDPig food 
(h) 
FEDFDA breakfast 
(h) 
FEDFDA breakfast
MCP 0.4 mg/kg
 
(h) 
FEDEnergy drink 
(h) 
FEDEnergy drink
MCP 0.4 mg/kg
 
(h) 
25 % 1.6 3.1 1.0 0.8 1.2 3.3 2.7 1.8 
50 % 3.2 4.6 2.8 1.9 2.4 4.6 3.7 2.8 
75 % 4.0 5.8 5.1 3.6 5.0 5.8 5.3 4.4 
*MCP= Metoclopramide 
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Figure legends 
Fig. 1. Plasma concentration time profile following intravenous administration of 240 mg of 
paracetamol to pigs (mean ± SEM, n = 6). 
 
Fig. 2. Fasted versus Fed. State, (A) plasma concentration profile after oral administration of 
paracetamol, = 𝐹𝐴𝑆𝑇𝐸𝐷 ; = 𝐹𝐸𝐷𝑃𝑖𝑔 𝑓𝑜𝑜𝑑 ; = 𝐹𝐸𝐷𝐸𝑛𝑒𝑟𝑔𝑦 𝑑𝑟𝑖𝑛𝑘 ; =  𝐹𝐸𝐷𝐹𝐷𝐴 𝑏𝑟𝑒𝑎𝑘𝑓𝑎𝑠𝑡 
(B)tmax (median ± range). (C) mean absorption time (median ± range). (D) deconvolution 
profile, = 𝐹𝐴𝑆𝑇𝐸𝐷; = 𝐹𝐸𝐷𝑃𝑖𝑔 𝑓𝑜𝑜𝑑; = 𝐹𝐸𝐷𝐸𝑛𝑒𝑟𝑔𝑦 𝑑𝑟𝑖𝑛𝑘; = 𝐹𝐸𝐷𝐹𝐷𝐴 𝑏𝑟𝑒𝑎𝑘𝑓𝑎𝑠𝑡; (Mean ± 
SEM, n = 6). 
 
Fig. 3. Effect of metoclopramide on fasted and fed states after oral administration of 
paracetamol of 1000 mg (Mean ± SEM, n = 5 - 6); A) plasma concentration profiles fasted state, 
𝐹𝐴𝑆𝑇𝐸𝐷 (), 𝐹𝐴𝑆𝑇𝐸𝐷𝑀𝐶𝑃 0.2 𝑚𝑔/𝑘𝑔 (), 𝐹𝐴𝑆𝑇𝐸𝐷𝑀𝐶𝑃 0.4 𝑚𝑔/𝑘𝑔(); B) mean deconvolution 
profiles fasted state, 𝐹𝐴𝑆𝑇𝐸𝐷 (), 𝐹𝐴𝑆𝑇𝐸𝐷𝑀𝐶𝑃 0.2 𝑚𝑔/𝑘𝑔 (), 𝐹𝐴𝑆𝑇𝐸𝐷𝑀𝐶𝑃 0.4 𝑚𝑔/𝑘𝑔 (); C) 
plasma concentration profile,  𝐹𝐸𝐷𝐹𝐷𝐴 𝑏𝑟𝑒𝑎𝑘𝑓𝑎𝑠𝑡  (), 𝐹𝐸𝐷𝐹𝐷𝐴 𝑏𝑟𝑒𝑎𝑘𝑓𝑎𝑠𝑡
𝑀𝐶𝑃 0.4 𝑚𝑔/𝑘𝑔
 (); D) mean 
deconvolution profiles, 𝐹𝐸𝐷𝐹𝐷𝐴 𝑏𝑟𝑒𝑎𝑘𝑓𝑎𝑠𝑡(), 𝐹𝐸𝐷𝐹𝐷𝐴 𝑏𝑟𝑒𝑎𝑘𝑓𝑎𝑠𝑡
𝑀𝐶𝑃 0.4 𝑚𝑔/𝑘𝑔
 ();E) plasma concentration 
profiles, Fresubin energy drink, 𝐹𝐸𝐷𝐸𝑛𝑒𝑟𝑔𝑦 𝑑𝑟𝑖𝑛𝑘  (), 𝐹𝐸𝐷𝐸𝑛𝑒𝑟𝑔𝑦 𝑑𝑟𝑖𝑛𝑘
𝑀𝐶𝑃 0.4 𝑚𝑔/𝑘𝑔
 (); F) mean 
deconvolution profiles, Fresubin energy drink, 𝐹𝐸𝐷𝐸𝑛𝑒𝑟𝑔𝑦 𝑑𝑟𝑖𝑛𝑘 (), 𝐹𝐸𝐷𝐸𝑛𝑒𝑟𝑔𝑦 𝑑𝑟𝑖𝑛𝑘
𝑀𝐶𝑃 0.4 𝑚𝑔/𝑘𝑔
 (). 
 
Fig. 4. Mean absorption times of paracetamol after oral administration of 1000 mg, plots show 
median ± range (n = 4 - 6). 
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